Disease & Medical Research
Fibrolamellar Cancer Foundation
GREENWICH, CT
Total revenue
$3.4M
Total expenses
$2.9M
Net assets
$6.9M
Grants received
$3.0M
101 grants
EIN
270341021
Tax year
2024
Mission
Fibrolamellar cancer foundation,(the "foundation") was established to raise awareness and research funds for fibrolamellar carcinoma, a rare form of liver cancer that is primarily seen in teens and young adults. Currently, there are no viable treatment options other than liver resection surgery. Our mission is to find a cure and reliable treatment options for those diagnosed with this rare disease as well as enhance communications among healthcare professionals and patients.
Financials
FY 2024
Revenue
Expenses
People
13 listed
KURT LOSERT
CEO
$251K
40 hrs/wk
ANNE ADLER
DIRECTOR
—
25 hrs/wk
JOHN CRAIG
DIRECTOR
—
1 hrs/wk
TAL FRIEDMAN
DIRECTOR
—
1 hrs/wk
MARNA O DAVIS
CO-CHAIRPERSON
—
25 hrs/wk
LESLIE GRAVES
TREASURER
—
1 hrs/wk
CRAIG MARTIN
DIRECTOR
—
1 hrs/wk
GUY LEVY
DIRECTOR
—
1 hrs/wk
CHARLES A DAVIS
CO-CHAIRPERSON
—
1 hrs/wk
CHARLES W BEERMANN
DIRECTOR
—
1 hrs/wk
DEREK GILCHRIST
DIRECTOR, SECRETARY
—
2 hrs/wk
DR MARK FURTH
CHIEF SCIENCE OFFICER
$165K
40 hrs/wk
PAYAL RAY
PROGRAM RESEARCH DIRECTOR
$154K
40 hrs/wk
Grants received
Showing 101 of 101
Funded by
$3.0M from 40 funders · 101 grants · 2017–2024
$752K · 8 grants · 2017–2023
$615K · 2 grants · 2020–2022
$513K · 7 grants · 2017–2023
$200K · 5 grants · 2018–2024
$156K · 4 grants · 2019–2024
$99K · 5 grants · 2018–2023
$75K · 5 grants · 2018–2024
$75K · 3 grants · 2020–2023